Free Trial

Morgan Stanley (NYSE:MS) Given Consensus Recommendation of "Hold" by Brokerages

Morgan Stanley logo with Finance background

Morgan Stanley (NYSE:MS - Get Free Report) has received a consensus rating of "Hold" from the seventeen analysts that are presently covering the stock, Marketbeat reports. Ten research analysts have rated the stock with a hold recommendation, six have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $136.69.

A number of analysts have weighed in on the company. JMP Securities reiterated a "market perform" rating on shares of Morgan Stanley in a research note on Monday, April 14th. Evercore ISI reduced their target price on Morgan Stanley from $150.00 to $138.00 and set an "outperform" rating on the stock in a research note on Tuesday, April 1st. The Goldman Sachs Group raised their price target on Morgan Stanley from $121.00 to $136.00 and gave the company a "neutral" rating in a research note on Tuesday, June 10th. Citigroup restated a "neutral" rating and set a $130.00 price target (up previously from $125.00) on shares of Morgan Stanley in a research note on Wednesday, June 18th. Finally, JPMorgan Chase & Co. cut their price target on Morgan Stanley from $125.00 to $122.00 and set a "neutral" rating on the stock in a research note on Monday, April 14th.

Check Out Our Latest Report on Morgan Stanley

Insider Buying and Selling at Morgan Stanley

In other Morgan Stanley news, insider Andrew M. Saperstein sold 40,000 shares of the business's stock in a transaction that occurred on Friday, May 2nd. The stock was sold at an average price of $120.00, for a total value of $4,800,000.00. Following the completion of the transaction, the insider directly owned 335,765 shares of the company's stock, valued at approximately $40,291,800. The trade was a 10.64% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Robert H. Herz sold 800 shares of the business's stock in a transaction that occurred on Friday, May 2nd. The shares were sold at an average price of $119.32, for a total value of $95,456.00. Following the completion of the transaction, the director directly owned 96,760 shares of the company's stock, valued at $11,545,403.20. The trade was a 0.82% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 50,868 shares of company stock valued at $6,019,548. 0.19% of the stock is owned by company insiders.

Institutional Trading of Morgan Stanley

Several large investors have recently made changes to their positions in the company. Alley Investment Management Company LLC lifted its stake in shares of Morgan Stanley by 75.0% in the 1st quarter. Alley Investment Management Company LLC now owns 62,469 shares of the financial services provider's stock valued at $7,288,000 after purchasing an additional 26,763 shares during the last quarter. Ethic Inc. lifted its stake in Morgan Stanley by 35.8% during the 4th quarter. Ethic Inc. now owns 162,269 shares of the financial services provider's stock worth $20,400,000 after acquiring an additional 42,743 shares in the last quarter. Pamalican Asset Management Ltd acquired a new position in Morgan Stanley during the 4th quarter worth about $4,513,000. Alpha DNA Investment Management LLC lifted its stake in Morgan Stanley by 112.0% during the 4th quarter. Alpha DNA Investment Management LLC now owns 39,921 shares of the financial services provider's stock worth $5,019,000 after acquiring an additional 21,090 shares in the last quarter. Finally, Sequoia Financial Advisors LLC lifted its stake in Morgan Stanley by 212.2% during the 1st quarter. Sequoia Financial Advisors LLC now owns 187,793 shares of the financial services provider's stock worth $21,910,000 after acquiring an additional 127,645 shares in the last quarter. 84.19% of the stock is currently owned by hedge funds and other institutional investors.

Morgan Stanley Stock Performance

MS stock opened at $142.25 on Monday. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 3.11. The business's fifty day simple moving average is $132.11 and its two-hundred day simple moving average is $126.70. Morgan Stanley has a twelve month low of $90.94 and a twelve month high of $145.16. The firm has a market cap of $228.21 billion, a price-to-earnings ratio of 16.70, a PEG ratio of 1.34 and a beta of 1.30.

Morgan Stanley (NYSE:MS - Get Free Report) last released its earnings results on Friday, April 11th. The financial services provider reported $2.60 earnings per share for the quarter, topping analysts' consensus estimates of $2.21 by $0.39. Morgan Stanley had a return on equity of 14.98% and a net margin of 12.98%. The business had revenue of $17.74 billion for the quarter, compared to analyst estimates of $16.81 billion. During the same quarter last year, the firm posted $2.02 earnings per share. The business's revenue was up 17.2% compared to the same quarter last year. Analysts predict that Morgan Stanley will post 8.56 earnings per share for the current year.

Morgan Stanley declared that its board has initiated a stock repurchase plan on Tuesday, July 1st that authorizes the company to repurchase $20.00 billion in outstanding shares. This repurchase authorization authorizes the financial services provider to buy up to 8.9% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's board of directors believes its shares are undervalued.

About Morgan Stanley

(Get Free Report

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.

Recommended Stories

Analyst Recommendations for Morgan Stanley (NYSE:MS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Morgan Stanley Right Now?

Before you consider Morgan Stanley, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Morgan Stanley wasn't on the list.

While Morgan Stanley currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines